Spelling suggestions: "subject:"glycemic control"" "subject:"glycemic coontrol""
81 |
QUALIDADE DE VIDA, SUPORTE SOCIAL E CONTROLE GLICÊMICO EM PORTADORES DE DIABETES MELLITUS TIPO2Franco Júnior, Alberto José de Amorim 06 December 2010 (has links)
Made available in DSpace on 2016-08-03T16:34:52Z (GMT). No. of bitstreams: 1
Alberto Jose de Amorim.pdf: 812252 bytes, checksum: 2b322172d1516118f32b2e4e84a62a87 (MD5)
Previous issue date: 2010-12-06 / Diabetes Mellitus is a chronic degenerative disease that requires a lot of limitations due to the need for constant treatment. Therefore, it was considered that the study of life
quality and social support could bring knowledge to improve the quality of interventions for these patients. The aim of this study was to evaluate the quality of life, social support and glycemic control in type2 diabetic patients. This is a descriptive and transversal study was conducted among 120 patients of both genders, who attended the outpatient endocrinology clinic of a hospital located in Sao Bernardo do Campo city. For data collection we used the following instruments: a questionnaire for population characteristics, quality of life questionnaire (WHOQOL-BREF) and the Scale of Perceived Social Support (EPSS). The data relating to glycemic control were collected from medical records of patients. For data analysis we used descriptive statistics and
statistical tests (Pearson, Chi-square, Fisher exact, ANOVA and Post hoc). The results indicated that the field of social relations was the largest contributor to quality of life.
And the variable time of diagnosis, insulin therapy, and number of dependents, education, diet and medication interfered with quality of life and quality of treatment.
These results call attention to the medical evaluations should be tied to assessments of quality of life, social support and also variables that affect the quality of treatment for that in this way can resize or enhance doings related interventions with these patients. / Diabetes Mellitus é uma doença crônica degenerativa que impõe uma série de limitações em função da necessidade de tratamento constante. Por isso, considerou-se que o estudo da qualidade de vida e suporte social poderia trazer
conhecimento para melhorar a qualidade das intervenções para estes pacientes. O objetivo deste trabalho foi avaliar a qualidade de vida, suporte social e controle glicêmico de portadores de Diabetes Mellitus tipo2. Trata-se de um estudo
descritivo e transversal, desenvolvido com 120 pacientes de ambos os gêneros, atendidos no ambulatório de endocrinologia de um hospital situado na cidade de São Bernardo do Campo. Para coleta dos dados foram utilizados os seguintes instrumentos: questionário para caracterização da população, questionário de qualidade de vida (WHOQOL-BREF) e a Escala de Percepção de Suporte Social (EPSS). Os dados referentes ao controle glicêmico foram coletados nos prontuários dos pacientes. Para análise dos dados utilizou-se à estatística descritiva e provas estatísticas (Pearson, QuiQuadrado, Exato de Fisher, Anova e Pos-hoc). Os resultados indicaram que o domínio das relações sociais foi o que mais contribuiu a qualidade de vida. E as variáveis tempo de diagnóstico,
insulinoterapia, número de dependentes, escolaridade, dieta e medicação interferiram na qualidade de vida e na qualidade do tratamento. Estes resultados chamam a atenção para que as avaliações médicas devam ser atreladas a avaliações da qualidade de vida, suporte social e também variáveis que interferem na qualidade do tratamento para que, desta forma possam redimensionar ou melhorar fazeres ligados às intervenções com estes pacientes.
|
82 |
Prevalência do uso de risco de álcool e de sintomas de ansiedade e de depressão em adolescentes e adultos jovens com diabetes mellitus tipo 1: estudo transversalKnychala, Maria Aparecida 15 July 2014 (has links)
Background: The medical literature shows that alcohol consumption is common among diabetic individuals and is associated with poor adherence to treatment, resulting in increased morbidity and mortality. However, no study has assessed the association between high-risk alcohol consumption and the presence of anxiety and depression in individuals with type 1 diabetes mellitus (1DM). Objectives: To know the degree of alcohol use, the prevalence at risk alcohol use and symptoms of anxiety and depression, the level of glycemic control and the association between these variables in adolescents and adults diagnosed with type 1 diabetes treated at the Clinic of Endocrinology Outpatient, Federal University of Uberlândia (UFU) and the Municipal Diabetic Care Center of Uberlândia. Methods: The present cross-sectional study assessed 209 outpatients in regards to alcohol consumption and the presence of anxiety and depression symptoms, using the Alcohol Use Disorders Identification Test (AUDIT), the Hospital Anxiety and Depression (HAD) scale, and glycemic control, according to the levels of glycated hemoglobin (HbA1c). The chi-square test and logistic regression analysis were used to investigate the association between the investigated variables. Results: The prevalence of high-risk alcohol consumption (AUDIT ≥ 8) among individuals with 1DM was high, specifically 24.88% among the entire group of subjects, 12.9% among the adolescents, 14.7% among the females, and 34.6% among the males. Upon comparisons based on gender and age, the odds of high-risk drinking were higher among males and participants aged 30 to 40 years (33.93%). The frequency of high-risk alcohol consumption did not differ as a function of gender among adolescents (females: 9.09%, males: 16.21%; p=0.374). Neither the frequency of anxiety (total: 29.66%, females: 37.25%, males: 22.43%) nor depression (total: 11%, females: 17.65%, males: 4.7%) symptoms exhibited associations with high-risk alcohol consumption. Moreover, the odds of female subjects exhibiting anxiety or depression symptoms were higher (odds ratio OR: 4.37 and OR: 7.4, respectively). Glycemic control was inadequate in most of the sample and did not exhibit an association with high-risk alcohol consumption or the presence of anxiety and depression symptoms. Conclusions: The prevalence of high-risk alcohol consumption and the presence of anxiety and depression symptoms were high in this patient sample. The frequency of high-risk drinking increased together with age and was greater among males; however, this frequency did not exhibit differences in terms of gender among adolescents. Glycemic control was inadequate in most of the sample independent of alcohol consumption and the presence of anxiety and depression symptoms. / Introdução: A literatura médica mostra que o uso de álcool é frequente em pacientes com diabetes e está associado à má adesão ao tratamento, o que pode levar a uma maior morbidade e mortalidade. Entretanto, faltam pesquisas que avaliem a associação entre o uso de risco de álcool e a presença de sintomas de ansiedade e de depressão em pacientes com diabetes tipo 1 (DM1). Objetivos: verificar o grau de utilização de álcool, a prevalência do uso de risco de álcool e de sintomas de ansiedade e de depressão, o nível de controle glicêmico e a associação entre essas variáveis em adolescentes e adultos com diagnóstico de DM1, atendidos no Ambulatório de Endocrinologia do Hospital de Clínicas da Universidade Federal de Uberlândia (UFU) e no Centro Municipal de Atenção ao Diabético de Uberlândia (CMAD). Métodos: Este estudo transversal avaliou 209 pacientes em tratamento ambulatorial, quanto ao consumo de álcool, à presença de sintomas de ansiedade e de depressão por meio dos testes de rastreamento Alcohol Use Disorders Identification Test (AUDIT) e Hospital Anxiety and Depression (HAD) e o controle glicêmico por meio da hemoglobina glicada (HbA1c). Utilizaram-se os testes estatísticos de qui-quadrado e regressão logística para verificar a associação entre as variáveis. Resultados: A prevalência do consumo de risco de álcool em pacientes com DM1 foi de 24,8%, sendo 14,7% em mulheres e 34,6% em homens. A chance de uso de risco foi maior nos homens (OR=2,79), em pessoas com faixa etária mais elevada (OR=1,07), naqueles com história familiar de uso de álcool (OR=7,05), nos que referiram consumo de drogas ilícitas (OR=5,89), cigarro (OR=8,25) e na faixa etária de 30 a 40 anos (OR = 1,07). Quanto ao consumo de risco na adolescência, não houve diferença entre os gêneros (mulheres=9,09% e homens=16.21% e p=0,374). As frequências de sintomas de ansiedade (11% no total, 17,65% nas mulheres e 4,7% nos homens) e de depressão (29,66% no total, 37,25% nas mulheres e 22,43% nos homens) não mostraram relação com o consumo de bebidas alcoólicas. As mulheres apresentaram mais sintomas de ansiedade (OR=2,05) e de depressão (OR=4,37) do que os homens, assim como os adultos com mais de 30 anos em relação aos mais jovens (OR=2,34 para ansiedade e OR= 7,44 para depressão). O controle glicêmico foi predominantemente inadequado e não se verificou associação com o uso de risco de álcool e com a presença de sintomas de ansiedade e de depressão. Não houve associação do nível de HbA1c com o uso de risco de álcool, provavelmente devido ao número pequeno de pacientes com bom controle glicêmico. Conclusões: A prevalência do consumo de risco de álcool e a presença de sintomas de ansiedade e de depressão em adolescentes e adultos com DM1 foram elevadas. O uso de risco de álcool aumentou proporcionalmente ao aumento da faixa etária e foi mais prevalente entre os homens; somente entre os adolescentes não houve diferença entre os gêneros. Na amostra estudada, o controle glicêmico foi inadequado na maioria dos pacientes,independentemente do consumo de álcool e da presença de sintomas de ansiedade e de depressão. / Mestre em Ciências da Saúde
|
83 |
Avaliação de diferentes modalidades de tratamentos em pacientes com diabetes mellitus tipo 2 e doença periodonal / Evaluation of different treatment modalities in patients with type 2 diabetes mellitus and periodonal diseaseToyama, Gisele 14 February 2014 (has links)
Made available in DSpace on 2017-07-10T18:55:44Z (GMT). No. of bitstreams: 1
Gisele Toyama.pdf: 2839416 bytes, checksum: 2f5dbd1ea8e1b9c003fdb5d06ee443c4 (MD5)
Previous issue date: 2014-02-14 / Type 2 diabetes (DM2) and periodontal disease are closely related. DM2 is a risk factor for periodontal disease whereas periodontitis increases hyperglicemia. Although it is known that the treatment of periodontitis improves glycemic control, there is no consensus of what type of treatment is best for diabetics. Objective: Evaluate different types of periodontal treatment in diabetics. Methodology: Two different researches were performed: 40 patients, aged 30 to 60, who were divided into 2 groups: group 1: controlled mechanical + basic periodontal treatment, Group 2: controlled mechanical + basic periodontal treatment + Doxycycline 100 mg orally for 14 days. In the first study, the analyses were made after 0, 3 and 6 months, including probing depth, level of clinical attachment, bleeding on probing. Glycated hemoglobin (HbA1c), fasting glucose and microbiological analysis (FG) were also taken. In study 2, a clinical analysis and an expression of isoforms of interleukin IL1β (IL-1β) test was performed. 20 patients were selected for the second part of the research. They were divided as follow: 1) Conventional periodontal treatment with scaling and root planning + Mechanical control and group 2) Periodontal Treatment (one-stage full-mouth disinfection) + Mechanical control . In this research, the analysis was performed after 0, 3 and 6 months including clinical evaluation, HbA1c and FG tests. The expression of isoforms of interleukin IL1β (IL-1β) were analyzed in the beginning of the study and after 6 months. Results: In the first article, it was shown an improvement in all clinical periodontal parameters evaluated as well as the level of HbA1c in both treated groups after 6 months. In the doxycycline group, there was a greater improvement in gingival index and test of glycated hemoglobin, as well as a smaller amount of Gram- .The second study showed a significant decrease in the expression of IL1- in gingival crevicular fluid in patients in treatment with Doxycycline. In the second research, after 6 months, it was observed better levels of FG, clinical periodontal parameters and gingival crevicular fluid in both groups. Nevertheless, no statistical significance was observed in the expression of IL-1β after 180 days. Conclusion: It is suggested that the basic periodontal therapy associated with the use of doxycycline is more efficient for clinical, glycemic and microbiological control in patients with type 2 Diabetes Mellitus with periodontal disease, as well as in the reduction of IL1- in gingival crevicular fluid. When different types of periodontal treatments are compared, it is possible to observe that the conventional periodontal treatment is the first choice in one-stage full-mouth disinfection for both glycemic control and periodontal parameters related to bleeding on probing and gingival crevicular fluid as well as the relation of variation envolving the expression of IL1-β even in the absence of significant difference among initial and final parameters in each group / O diabetes mellitus tipo 2 (DM2) e a doença periodontal possuem entre si uma relação íntima. O diabetes é um fator de risco para periodontite, assim como, a periodontite aumenta a hiperglicemia. O tratamento da periodontite pode melhorar o controle glicêmico, entretanto, não existe consenso de qual tratamento periodontal é o melhor em diabéticos. Objetivo: Avaliar diferentes modalidades de tratamento periodontal em diabéticos. Metodologia: Foram realizadas duas pesquisa, na primeira, foram selecionados 40 pacientes com DM2, e estes divididos em dois grupos: Grupo 1: Controle mecânico + Tratamento periodontal básico; Grupo 2: Controle mecânico + Tratamento periodontal básico + Doxiciclina 100 mg via oral por 14 dias. No primeiro artigo foram realizadas análises aos 0, 3 e 6 meses, incluindo Profundidade de sondagem, Nível de inserção clínica e Sangramento a sondagem, juntamente com a avaliação de hemoglobina glicada (HbA1c), glicemia em jejum (GJ) e análise microbiológica. No artigo 2, foram realizadas as análises clínicase a análiseda expressão das isoformas da interleucina IL1β (IL-1β). Na segunda pesquisa foram selecionados 20 pacientes com DM2, os quais foram divididos em dois grupos: Grupo 1: Tratamento periodontal básico (RAR) + Controle mecânico (Técnica de Bass + fio dental); Grupo 2: Tratamento periodontal básico (Desinfecção Total de Boca em Estágio Único - DBEU) + controle mecânico (Técnica de Bass + fio dental). Nesta pesquisa as análises também foram realizadas aos 0, 3 e 6 meses, com avaliação clínica periodontal e a avaliação de HbA1c e GJ. A expressão das isoformas de IL-1β foram analisadas no início e após 6 meses. Resultados: No primeiro artigo, houve uma melhora de todos os parâmetros clínicos periodontais e dos níveis de HbA1c em ambos os grupos tratados após 6 meses. No grupo que usou doxiciclina, houve uma melhora mais expressiva do índice gengival e daHbA1c, bem como uma quantidade menor de microrganismos Gram-. O segundo artigo evidenciou uma expressão significantemente menor de IL1- no fluido crevicular gengival dos pacientes em uso de doxiciclinina ao final do experimento. Na segunda pesquisa, após 6 meses, houve uma melhora da GJ, dos parâmetros clínicos periodontais e da quantidade de fluido crevicular gengival em ambos os grupos. Entretanto, não houve diferença estatisticamente significativa na expressão de IL-1β após 180 dias.Conclusão: Foi possível observar que a terapia periodontal básica associada ao uso de doxiciclina é mais eficiente para o controle clínico, glicêmico e microbiológico de pacientes portadores de DM2 e doença periodontal, bem como na menor expressão de IL1- no fluido crevicular gengival deste pacientes. Quando comparado os tipos de tratamento periodontal, foi possível observar que o tratamento periodontal convencional é superior à desinfecção total em estágio único, tanto em relação ao controle glicêmico, quanto em relação aos parâmetros periodontais de sangramento a sondagem e área de fluido gengival, bem como em relação a variação dos valores de expressão de IL1-β,
apesar de não haver diferença significativa entre os valores iniciais e finais em cada grupo
|
84 |
Self-management for Type 2 Diabetes Mellitus Patients in Mexico - Nurses' perspective : A qualitative studyFernández Sánchez, Montserrat January 2020 (has links)
Bakgrund: Diabetes Mellitus Typ 2 är en kronisk sjukdom som ger allvarliga långsiktiga skador. En av hörnstenarna för att kontrollera sjukdomen är patientens egenvård. För att genomföra behandlingen måste patienterna förstå vilken betydelse de har för sjukdomen. Syfte: Syftet med denna studie är att beskriva Mexikaner sjuksköterskornas upplevelse om deras bidrag till kännedom om egenvård hos patienter med Diabetes Mellitus Typ 2 i Mexiko. Metod: En kvalitativ design med semi-strukturerade intervjuer och en innehållanalys användes i denna studie. Resultat: Deltagarna upplever att egenvård är av stor betydelse vid behandling av Diabetes Mellitus typ 2. Patienterna behöver kunskap och utbildning, och sjuksköterskorna är medvetna om att de är ansvariga för undervisningen. Däremot på grund av tidsbrist, otillräcklig personal samt överbelastning av patienter kan inte utbildning av patienter ske. Enligt deltagarna är patienternas engagemang och familjestöd faktorer som påverkar patienternas egenvård. Slutsats: Deltagarna upplever att egenvård är viktigt för Diabetes Mellitus typ 2. Patienten och sjuksköterskorna har en viktigt roll vid egenvård. En personcentrerad vård kan hjälpa sjuksköterskor att tillgodose patienternas behov. / Background: Type 2 Diabetes Mellitus is a chronic disease that produces serious long-term complications. The self-management of the patient has become the cornerstones to control the disease. To carry out treatment, patients must understand the role they play at this. Aim: This study aims to describe the Mexican nurses’ perception of their contribution to the knowledge of self-management in patients with T2DM in Mexico. Method: A qualitative approach with semi-structured survey and a content analysis was used in this study. Result: The participants perception is that self-management is of great importance in the treatment of T2DM. However, patients need education and knowledge, and the nurses are aware that they are responsible for that education. Nevertheless, the lack of time, inadequate nurse staffing and overwhelming number of patients, are causes that are not allowing them to educate the patients. According to the participants, the engagement of the patients and family support are factors affecting the patients’ self-management. Conclusions: The participants perception is that self-management is crucial for T2DM patients and the nurses have an important role in it. The use of a Person-Center Cared approach can help the nurses meet the needs of the patients.
|
85 |
Nové trendy v monitoraci a kontrole glykémie v perioperačním období. / New trends in perioperative monitoring and glycaemic control.Lipš, Michal January 2019 (has links)
Glycaemic control in critically ill patients has been a topic of considerable attention for the past 20 years. In literature and at scientific meetings, there have been ongoing debates regarding the efficacy of glycaemic control in these patients with frequently entirely opposite opinions. These range from a strict invasive approach with target glycaemia 4-6 mmol/l to a liberal approach tolerating even values higher than 12 mmol/l. In the preview of this PhD thesis we have analysed so far published literature and describe the reasons for this inconsistency. According to the results of recent studies, the most significant efficacy of tight glycaemic control has been observed in cardiac surgical patients. If we consider the concept of tight glycaemic control as efficient strategy, there are three important questions remaining unanswered as follow. Does the specific algorithm-protocol play a key part in the concept of tight glycaemic control alongside the knowledge and skills of nursing staff in safe and efficient blood glucose control? What is the ideal timing of starting the strategy of tight glycaemic control (TGC) in cardiac surgical patient? And is there any benefit in outcome respect to mortality or morbidity? Do we have any more safe and efficient option or add-on to standard perioperative...
|
86 |
Associations Between Glycemic Control and Executive Functioning in Type 1 Diabetes: A Systematic Review and Meta-AnalysisMcDaniel, Hannah Margot 16 August 2022 (has links)
Research conducted with youth with type 1 diabetes (T1D) has shown that glycemic extremes and poorer T1D management are associated with poorer performance on measures of executive functioning (EF) compared to non-T1D counterparts. Deficits in EF may negatively impact the development of healthy T1D management skills. Our primary aim was to conduct a meta-analytic review of previous studies investigating the associations between glycemic control and EF in children with T1D across the developmental span. Comprehensive literature searches were conducted using PubMed, MedLine, PsycInfo, Google Scholar, and EBSCO for articles that met eligibility criteria. Eligibility criteria included correlational, randomized, and non-randomized studies published after 1985 involving participants ages 0-26 with a diagnosis of T1D. Studies evaluated EF using the Behavior Rating Inventory of Executive Functioning (BRIEF) or fMRI and evaluated glycemic control using Hemoglobin A1c. Across twelve studies examining the effect of glycemic control on EF in patients with T1D, 2,204 children, adolescents, and emerging adults were included in the study. Effect sizes (Hedges' g) were calculated between the T1D group and either control participants or a normative sample. Participant age was included as a moderator to determine whether the hypothesized association varied in magnitude across development. Participant A1c was used as a moderator to determine whether the hypothesized variation varied with diabetic management. A trend towards poorer performance on measures of executive functioning was observed in the T1D group compared to the normative sample (g = -0.22). In comparing age cohorts to the normative sample, a significantly poorer performance on measures of EF was observed in the 9-11, 15-17, and 18-26 age cohorts (g = -0.201, -0.258, and -0.452, respectively) compared to other age cohorts. Overall, research indicates that poor diabetic management may result in poorer performance on measures of EF compared to non-diabetic participants. These findings imply that this trend of poorer EF in children and adolescents with type 1 diabetes may lead to suboptimal diabetic management. Research suggests that suboptimal diabetic management often persists across the lifespan. Examining this association across critical periods where diabetes management may exert the most influence on the developing brain may provide guidance about when youth may benefit most from T1D management interventions.
|
87 |
Efectividad de la telesalud en el manejo de la diabetes mellitus tipo 2 en el Hospital Regional Lambayeque-2021Noblecilla Cruz, Paola Adriana January 2024 (has links)
Introducción: La pandemia por COVID-19 resaltó la importancia de un buen control glicémico de pacientes con diabetes mellitus tipo 2 para evitar complicaciones; sin embargo, también limitó el tratamiento y seguimiento de estos pacientes. En este contexto el uso de la telesalud fue promovido. Objetivo: Determinar la efectividad de la telesalud en el manejo de la diabetes mellitus tipo 2 en el Hospital Regional Lambayeque durante el año 2021. Materiales y métodos: estudio de cohortes retrospectivo, realizado en base de historias clínicas de pacientes diagnosticados con DM2 atendidos por teleconsulta de enero a marzo del 2021 que hubieran sido atendidos previamente de manera presencial y contarán con controles glicémicos.
Resultados: Los pacientes con DM2 tuvieron una edad promedio de 60.73 ± 8.93 años, predominio del género femenino (70.7%), el 28.3% tenían más de 10 años de evolución y el 56.6% se trataba con antiglicémicos orales. La complicación más frecuente fue la neuropatía (46.5%) y la comorbilidad la IRC (18.2%). Solo 2-3% de los pacientes presentaron síntomas de hiperglicemia e hipoglicemia. En cuanto a las glicemias en ayunas obtenidas de manera presencial y por telesalud no tuvieron diferencia significativa. (p = 0.8) La hemoglobina glicosilada encontrada en el seguimiento presencial fue de 8.17 ± 2.34 y por telesalud fue de 8.53 ± 2.65, siendo significativa la diferencia entre ambas modalidades. (p = 0.021) Conclusión: El control glicémico obtenido por telesalud fue estadísticamente menor que el
obtenido por vía presencial. (p=0.021) / Introduction: The COVID-19 pandemic highlighted the importance of good glycemic control in patients with type 2 diabetes mellitus to avoid complications; however, it also limited the treatment and follow-up of these patients. In this context the use of telehealth was promoted. Objective: determine the effectiveness of telehealth in the management of type 2 diabetes mellitus at the Lambayeque Regional Hospital during the year 2021. Materials and methods: retrospective cohort study, conducted based on medical records of patients diagnosed with DM2 attended by teleconsultation from January to March 2021 who had previously been attended in person and had glycemic controls. Results: Patients with DM2 had a mean age of 60.73 ± 8.93 years, with a predominance of women (70.7%), 28.3% had more than 10 years of evolution, and 56.6% were treated with oral antiglycemics. The most frequent complication was neuropathy (46.5%) and comorbidity CKD (18.2%). Only 2-3% of the patients presented symptoms of hyperglycemia and hypoglycemia. Regarding fasting glycemia obtained in person and by telehealth, there was no significant difference (p = 0.8). The glycosylated hemoglobin found by telehealth was 8.53 ± 2.65 and in the face-to-face follow-up it was 8.17 ± 2.34, the difference between both modalities being significant. (p = 0.021) Conclusion: The glycemic control obtained by telehealth was lower than that obtained in person. (p=0.021)
|
88 |
Effekten av intensivbehandling på HbA1c och hälsa hos individer med diabetes typ 1Berntsen, Tom, Dahlbom, Emma January 2024 (has links)
Bakgrund: Glykemisk kontroll hos personer med typ 1 diabetes kräver stöd och utbildning av vårdpersonal inom diabetesvården. För att förbättra behandlingsresultat och livskvalitet samt minska risken för komplikationer kan intensiva behandlingsstrategier användas för att sträva efter optimal glykemisk kontroll och hälsa. Syfte: Syftet är att beskriva hur intensivbehandling påverkar HbA1c och hälsa hos personer med diabetes typ 1. Metod: En retrospektiv studie, deskriptiv design med kvantitativ ansats. Urvalet skedde från en diabetesmottagning och utgick från redan insamlade data från ett intensivbehandlingsprojekt. 42 patienter med diabetes typ 1 och HbA1c ≥70 mmol/mol inkluderades i intensivbehandlingsprojektet. De variabler som undersöktes var HbA1c och EQ-VAS, för att undersöka sambandet mellan glykemiskkontroll och skattad hälsa. Huvudresultat: Resultatet visade ett svagt samband mellan sjunkande HbA1c och stigande EQ-VAS vid uppföljningen. Det starkaste signifikanta sambandet sågs i kategorin kontakt med dietist, kopplat till HbA1c och EQ-VAS. I kategorierna patienter med flerdosbehandling av insulinpenna, behandling med insulinpump samt utebliven kontakt med dietist visade inget signifikant samband kopplat till sjunkande HbA1c och stigande EQ-VAS. Slutsats: Studien visar betydande förbättringar i både HbA1c och EQ-VAS hos patienter med diabetes typ 1 efter intensivbehandling. Positiva samband observerades mellan insulinpumpbehandling och högre EQ-VAS, samt dietistkontakt och minskat HbA1c. Fynden tyder på att intensivbehandlingen, särskilt med dietistrådgivning, effektivt förbättrar glykemisk kontroll och livskvalitet. Ytterligare forskning behövs för att bekräfta dessa resultat. / Background: Glycemic control in individuals with type 1 diabetes requires support and education from diabetes care professionals. To improve treatment outcomes and quality of life while reducing the risk of complications, intensive treatment strategies can be employed to achieve optimal glycemic control and health. Purpose: The purpose is to describe how intensive treatment affects HbA1c and health in individuals with type 1 diabetes. Method: A retrospective study with a descriptive design using a quantitative approach. The sample was selected from a diabetes clinic and relied on previously reported data from an intensive treatment project. 42 patients with type 1 diabetes and HbA1c ≥70 mmol/mol were included in the intensive treatment project. Data were analyzed using Spearman's rank correlation analysis to identify relationships between HbA1c and health. Main Results: The results showed a weak correlation between decreasing HbA1c and increasing EQ-VAS scores at follow-up. The strongest significant correlation was observed in the category of contact with a dietitian, linked to HbA1c and EQ-VAS. In the categories of patients using multiple daily injections with insulin pens, insulin pump therapy, and lack of contact with a dietitian, no significant correlation was found related to decreasing HbA1c and increasing EQ-VAS. Conclusion: The study shows significant improvements in both HbA1c and EQ-VAS in patients with type 1 diabetes after intensive treatment. Positive correlations were observed between insulin pump therapy and higher EQ-VAS scores, as well as between dietitian contact and reduced HbA1c. The findings suggest that intensive treatment, especially with dietitian counseling, effectively enhances glycemic control and quality of life. Further research is needed to confirm these results.
|
89 |
Psicoterapia breve operacionalizada em gestantes diabéticas 1 com mau controle glicêmico / Operationalized Brief Psychotherapy in diabetic 1 pregnant women with deficient glycemic controlLivia Maria Ramos Batista 10 December 2015 (has links)
O Ministério da Saúde adverte que o Diabetes Mellitus é um problema de saúde pública devido sua alta taxa de prevalência. Estudos demonstram a correlação entre o funcionamento psicodinâmico de pacientes com diabetes mellitus tipo 1 e o controle glicêmico. Considerando que o controle glicêmico adequado minimiza os riscos para a mãe, o feto e o futuro bebê, salienta-se a importância de um atendimento psicoterápico na fase gestacional. Contudo, não existem pesquisas sobre Psicoterapia Breve Operacionalizada (PBO) enquanto técnica terapêutica para este tipo de população. O objetivo da pesquisa foi investigar possibilidades e limites da PBO no atendimento a gestantes portadoras de diabetes mellitus tipo 1 (DM1) com mau controle glicêmico. A metodologia utilizada para a pesquisa foi o clinico-qualitativo. O estudo envolveu quatro gestantes portadoras de DM1 com mau controle glicêmico. As gestantes foram encaminhadas pela Clínica Obstétrica do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, local onde as mesmas são atendidas. Foram utilizados como instrumentos: entrevista clínica psicológica; Escala Diagnóstica Adaptativa Operacionalizada; e Psicoterapia Breve Operacionalizada. As gestantes que concordaram em participar assinaram o Termo de Consentimento Livre e Esclarecido que após lido e explicado, foi assinado pela pesquisadora e gestante. Foram realizadas duas ou três entrevistas inicias para o diagnóstico adaptativo operacionalizado e planejamento da PBO. O número de sessões utilizadas para PBO foi definido conforme o diagnóstico adaptativo da gestante e sua situação-problema. As entrevistas e as sessões psicoterápicas tiveram duração de 45 minutos e frequência de uma vez por semana. A análise dos resultados foi realizada através da comparação entre o diagnóstico adaptativo operacionalizado realizado antes e depois da PBO. Foi verificado se ocorreu nas gestantes, durante estes períodos, mudanças adaptativas; além da averiguação das alterações no controle glicêmico, antes e após a PBO. A pesquisa expôs que houve mudanças de grupo adaptativo da qual as gestantes pertenciam. Cecília e Beatriz obtiveram melhora no diagnóstico adaptativo. Por intermédio do acompanhamento da evolução do controle glicêmico, pode-se verificar alterações com o decorrer da PBO: a porcentagem de hipoglicemias e hipoglicemias graves melhoraram; as porcentagens de valores alterados e de hiperglicemias, por sua vez, tiveram piora com o decorrer da gravidez, e, mesmo com a PBO, o rigoroso controle alimentar e insulinoterapia, inclusive em internações, foram dificilmente controlados. Das quatro gestantes estudadas duas tiveram crise adaptativa e as soluções encontradas por elas foram satisfatórias. O que pode restringir o processo psicoterapêutico é a transferência negativa persistente, contudo, ela pode ser trabalhada e minimizada. As possibilidades da PBO no atendimento às gestantes com DM1 encontradas na pesquisa foram: melhorar a eficácia da adaptação; auxiliar as pacientes em crise a solucionarem-na sem a queda da eficácia da adaptação; e, possibilitar as pacientes encontrarem soluções mais adequadas para suas situações-problema / The health ministry adverts that Diabetes Mellitus is a public health concern due to its high prevalence rate. Studies demonstrate the existing relation between the psychodynamic functioning of patients with type 1 diabetes mellitus and the glycemic control. Considering that the adequate glycemic control minimizes risks for the mother, fetus and the future baby, it reinforces the importance of psychotherapeutic treatment during the pregnancy. However, there arent any researches on Operationalized Brief Psychotherapy (OBP) as a therapeutic technique for this kind of population. The aim of the research was to investigate the possibilities and the limits of OBP in the treating of pregnant women with type 1 diabetes mellitus with deficient glycemic control. The methodology used for the research was the clinical-qualitative method. The study involved four pregnant women with DM1 with deficient glycemic control. The women were appointed by the Obstetric Clinic of the Hospital das Clínicas da Faculdade de Medicina from the University of São Paulo, place where they were already being treated. The instruments employed were Psychological Interviews, the Operationalized Adaptive Diagnosis Scale and Operationalized Brief Psychotherapy. The women who agreed to take part in the research signed a consent form that, after read and explained, was then signed by the research agent and the subjects. Two or three initial interviews took place for the Operationalized Adaptive Diagnosis and the planning of the. The number of sessions employed for the OPB was defined in accordance to the adaptive diagnosis of the subject and their problem-situation. The interviews and the psychotherapeutic sessions lasted 45 minutes with the frequency of once a week. The analysis of the results was made through the comparison between the operationalized adaptive diagnosis done before and after the OPB. During these periods, it was verified if there were any adaptive changes in the subjects and, moreover, the analysis of any alterations in the glycemic control before and after the OPB. The research showed that there were changes in the adaptive group to which the subjects belonged. Cecília and Beatriz had an improvement in the adaptive diagnosis. Through the analysis of the evolution of the glycemic control, it was possible to verify alterations during the OPB: the percentage of both hypoglycemia and severe hypoglycemia showed improvement; however, the percentage of altered rates and of hyperglycemia showed a downturn throughout the pregnancy and, even with the OPB, a strict diet control and insulin therapy, including during admissions, were hardly controlled. From the four pregnant women in the study, two of them had an adaptive crisis and the solution found by them was satisfactory. What can restrict the therapeutic process is the persisting negative transference, however, it can be minimized. The possibilities of the OPB in the treatment of pregnant women with DM1 found with the research were: improving the efficiency of the adaptation, assisting patients in crisis to resolve them without losses in adaptation efficiency and, make patients more able to find more adequate solutions to their problem-situations
|
90 |
Optimisation du contrôle glycémique des patients atteints de diabète de type 1 : traitement efficace des hypoglycémies, calcul des glucides et pancréas artificielGingras, Véronique 09 1900 (has links)
No description available.
|
Page generated in 0.0766 seconds